hypothesis that the repair of larger varicoceles would be associated with an increased improvement.
INTRODUCTION AND OBJECTIVES:
Hypogonadism is estimated to effect between 2.1% and 12.8% of men. Current therapies to treat hypogonadism include testosterone replacement therapy (TRT) and Clomiphene Citrate (CC) as an off-label use. In June 2014, the US Food and Drug Administration mandated that manufacturers of all testosterone replacement therapy products add a label warning of increased risk of deep vein thrombosis (DVT) due to post market reports of increased DVT incidence in men on TRT. However, current literature supporting an increased risk of DVT with TRT usage is sparse. Although not designed for treatment of hypogonadism in men, the package insert for CC includes pulmonary embolism (PE), an end sequela of DVT. We sought to evaluate the risk of DVT in men treated with TRT or CC and to assess other etiologies for DVT as potential factors.
METHODS: A retrospective chart review was performed of 1,180 consecutive men presenting for a hypogonadism evaluation who were treated with either TRT or CC.
RESULTS: Of the 1,180 men with hypogonadism, 694 were treated with TRT, while 486 were treated with CC. Overall, 10/1180 (0.8%) men treated with TRT or CC were diagnosed with a DVT during the treatment interval. Of the 10 men diagnosed with DVT while on treatment, seven (70%) had potential identifiable etiologies for DVT other than treatment for hypogonadism. Etiologies included lower extremity trauma, surgery, travel, Klinefelter's syndrome, and Factor V Leiden deficiency. None of the men were found to be polycythemic at the time of DVT diagnosis.
There was a higher incidence of DVT in men treated with TRT than CC; however, the overall percentages of DVT in both treatment groups were relatively low. When comparing the TRT and CC groups, there was no difference in the percentages of men found to have other identifiable etiologies for DVT besides being on treatment. There was no difference in testosterone levels between the TRT and CC groups.
CONCLUSIONS: The overall rates of DVT for TRT and CC treated patients at therapeutic levels are relatively low, and most patients with DVT had other identifiable etiologies for DVT. Polycythemia was not found to be a risk factor in the patients diagnosed with DVTs. METHODS: Data was extracted from our Men's Health registry for men with orchialgia who had MDSC between Sept 2010 and Aug 2018. All patients had unexplained scrotal contents pain for at least 4 months and reported temporary resolution of their pain following a cord block with lidocaine and bupivacaine.
Source of
RESULTS: There were 72 procedures in 61 patients (11 staged bilateral). Age ranged from 20 to 71 years (mean 41.9). Symptom duration ranged from 4 to 480 months (median 24). 12 patients had prior vasectomy and 35 patients had no prior genital surgery. At last follow up (range 3 months-7 years) 61 procedures led to complete pain resolution (84.7%). In men with post-vasectomy pain, 10 of 12 were successful (83%). Of the 11 procedures that did not resolve pain, 3 patients admitted the cord block did not fully work and 4 patients had unresolved pelvic floor spasm. There was no difference in age or symptom duration by surgical outcome. Surgical complications included 1 orchiectomy (patient had 2 prior surgeries), 1 hydrocele and 2 superficial wound infections. In 8 patients with complex anatomy and/or scarring we performed a more limited targeted dissection popularized by Parekattil et al in which only the spermatic fascia, vas and posterior fat were divided or stripped. In these men pain resolved in 7 cases (87.5%) CONCLUSIONS: MDSC can provide durable pain relief in most patients with orchialgia with minimal morbidity. Age, duration, prior vasectomy or a targeted limited dissection did not adversely impact outcome. Failure of cord block to eliminate pain and presence of pelvic floor spasm were the strongest predictors of persistent pain INTRODUCTION AND OBJECTIVES: Chronic orchialgia, defined as unilateral or bilateral scrotal pain lasting at least three months in duration, is one of the most common complaints seen in the urologist's office, and continues to be a challenging entity to diagnose and to treat. A careful history may elucidate the etiology in some men to be due to a hyperactive cremaster muscle reflex with testicular retraction. The objective of the study was to evaluate outcomes and complications in men who underwent microsurgical subinguinal cremaster muscle release (MSCMR).
METHODS: A retrospective chart review was performed on men who underwent MSCMR by a single surgeon between September 2011 and July 2018.
RESULTS: Between September 2011 and July 2018, fifteen men who presented with chronic orchialgia secondary to a hyperactive cremaster muscle reflex underwent MSCMR, six bilateral and nine unilateral. The mean age of the men was 39 years AE 11. Candidacy for MSCMR included answering yes to the clinical question: "at times of testicular pain, does the testicle retract up in the groin to the extent that you have to milk it back down to the scrotum?" They must also have had normal digital rectal examinations, negative urinalyses, negative scrotal Doppler ultrasounds, and had pain localized to the testicle, epididymis, or spermatic cord, without an anatomic or pathologically identifiable etiology other than testicular retraction. Of the men who underwent MSCMR, 100% (15/15) had resolution of testicular retraction and 86.7% (13/15) had complete resolution of orchialgia. One of the men had a complication (6.7%) which was a scrotal hematoma which resolved with conservative management. No patients had a surgical infection or testicular atrophy.
CONCLUSIONS: MSCMR is an effective option for men with orchialgia secondary to testicular retraction due to a hyperactive cremaster muscle reflex.
Source of Funding: None

MP53-03 ORIGIN OF FOURNIER GANGRENE AS A PROGNOSTIC FACTOR IN MORTALITY: ANALYSIS OF 121 CASES
David Adrian Fernandez Alcaraz*, Guadalupe, Mexico; Jhonataan Uribe Montoya, Andres Guillen Lozoya, Rodrigo Romero Mata, Monterrey, Mexico
INTRODUCTION AND OBJECTIVES: Fournier gangrene (FG)
is a severe life-threatening infection of the genital and perineal area. it continues to be a challenge for the physician in general and is considered a mortal urological emergency.
Objective: Evaluate the origin of Fournier gangrene (FG) is a prognostic factor of morbidity and mortality.
METHODS: Patients who came to our clinic with a diagnosis of FG from 2010 to 2017 were included retrospectively. Patients were categorized depending on the origin of the infection. Three severity factors were determined in each group, days of hospital stay, the FG severity index (FGSI), and mortality. The chi-square test and logistic regression were used to perform the statistical analysis of the results. RESULTS: Of the 130 patients evaluated, the origin was established in 121 based on the clinical history and radiological and surgical findings. A total of 34 patients had an intestinal origin with a mean age of 50 years, a mean hospital stay of 10.8 days, a mean FGSI of 5.17, and a mortality of 17.14%. A total of six patients had a testicular origin with a mean age of 48.08 years, a mean hospital stay of 5.46 days, a mean FGSI of 3.02, and a mortality of 2.17%. Twelve patients had a urinary origin with a mean age of 56.5 years, a mean hospital stay of 11.25 days, a mean FGSI of 4.5, and a mortality of 0%. There were 28 patients with a cutaneous origin with a mean age of 46.4 years, a mean hospital stay of 7.4 days, a mean FGSI of 5.14, and a mortality of 14.28%. The testicular origin was the most frequent (38%) in addition to presenting a lower hospital stay, a lower FGSI, and a lower mortality than those with an intestinal origin 5.6 AE 3 days (2.1%) vs 10.8 AE 5.1 days (17.14%), respectively, p[0.005.
CONCLUSIONS: Early emphasis on treatment, which should be aggressive from the beginning, reduces mortality in patients with FG. The FGSI is useful and should be applied in each patient to establish severity; the origin should also be established to determine short, medium and long-term survival. The testicular origin is statistically significant with a good prognosis in relation to mortality.
Source of Funding: none
MP53-04 COMPARISON OF DELAYED PRIMARY CLOSURE VERSUS SECONDARY INTENTION HEALING IN FOURNIER'S GANGRENE
INTRODUCTION AND OBJECTIVES: Fournier's gangrene (FG) is defined as necrotizing fasciitis of the genitalia and perineum. Despite medical advances, FG continues to be a devastating disease with mortality rates up to 50%. Management includes broad-spectrum antibiotics, fluid resuscitation, and aggressive debridement of necrotic tissue. Surgical debridement leads to large soft tissue defects requiring additional treatment modalities. We sought to identify factors and outcomes between patients managed with delayed primary closure (DPC) versus secondary intention (SI).
METHODS: All patients who presented to our institution with a diagnosis of FG between 2013 and 2017 were identified. Patients who were less than 18 years old or were transferred from an outside institution were excluded. Retrospective demographic information and clinical data was collected. Quality of life was assessed using the Wound QoL questionnaire, which comprises of 17 questions on a 5-point Likert-type scale.
RESULTS: A total of 37 patients were identified. Demographics other than age were statistically similar (see Table 1 ). Length of stay and time to intervention were similar between groups (p[0.286 and p[0.081). Wound size was larger in the SI group but this difference was not statistically significant (p[0.347). DPC patients were more likely to undergo secondary and tertiary operations from the initial operation (p [ 0.010, p[0.047) . DPC patients were also more likely to use additional treatment modalities such as negative pressure dressings (p [ 0.045) or utilization of flaps or grafts (p [ 0.017). Quality of life was assessed among 44% of living patients. DPC patients were found to have significantly better quality of life scores compared to SI patients (p[0.032).
CONCLUSIONS: Patients treated with DPC had smaller wounds that benefited from additional treatment modalities to achieve wound closure after resolution of the active infection. Additionally, DPC
